DiscoverStartupsPomelo Care
Pomelo Care company logo
Pomelo Care
Actively Hiring
The national leader in evidence-based healthcare for women and children501-1000 Employees
  • B2B
  • Growth Stage
    Expanding market presence
  • Top Investors
    This company has received a significant amount of investment from top investors

Pomelo Care careers

The national leader in evidence-based healthcare for women and children
Pomelo Care is the national leader in evidence-based healthcare for women and children. We deliver personalized, high-quality clinical interventions from reproductive care and pregnancy, infant care and pediatrics, to hormonal health through perimenopause and menopause, with long-term preventive care and condition management. Our model delivers 24/7 multispecialty care to address the medical, behavioral, and social factors that most significantly impact outcomes for women and children. We partner with payers, employers, and providers to expand access to quality healthcare across the system.

To search career opportunities or to learn more, head to pomelocare.com.
1 day ago

Manager, Growth

New York City • United States • San Francisco
$95k – $120k
2 days ago

Senior Manager, Growth

New York City • United States • San Francisco
$130k – $150k
2 days ago

Senior/Staff Security Engineer

Remote only • United States
$190k – $260k
4 days ago

Senior Manager, Internal Communications

New York City • United States • San Francisco
$140k – $160k
1 week ago

RVP, Labor, Trust and Public Sector Partnerships

New York City • United States • San Francisco
$165k – $185k
1 week ago
2 weeks ago

Midlife Registered Dietitian (Contract) - Licensed in Ohio

New York City • United States • San Francisco
2 weeks ago

Midlife Registered Dietitian (Contract) - Licensed in Pennsylvania

New York City • United States • San Francisco
2 weeks ago

Midlife Registered Dietitian (Contract) - Licensed in Michigan

New York City • United States • San Francisco
2 weeks ago
Marta Bralic Kerns
Avatar for Marta Bralic Kerns
Valuation

$1.7B

Funded over

4 rounds

Latest round

Series C (Jan 2026)